ESRRA and breast cancer: Our results show that miR-137, a potential tumor suppressor microRNA, can negatively modulate the expression of ERRα and suppress the growth and migration of breast cancer cells partly through two immediate downstream effectors of ERRα-cell cycle protein cyclinE1 and WNT11.